Menu Search
Equities

Oakridge International Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
U9O0:STU

Oakridge International Ltd

Actions
  • Price (EUR)0.033
  • Today's Change-0.003 / -7.04%
  • Shares traded0.00
  • 1 Year change+4.76%
  • Beta2.1026
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Oakridge International Limited is an Australia-based Internet of things (IoT) and healthcare technology company. The Company is primarily engaged in the business of selling professional healthcare technology equipment and solutions to healthcare facilities. The Company’s segments include Healthcare technology, Technology development and Geothermal projects. The Technology development segment is focused on the IoT technology. The Healthcare technology segment operates through its wholly owned subsidiary, JCT Healthcare Pty Ltd (JCT), which is a provider of technology solutions for the healthcare sector. JCT develops and distributes its own range of nurse call hardware and software solutions for use across multiple healthcare sectors including hospitals, aged care, disability care and supported independent living. The Geothermal projects segment includes Sokoria Geothermal Project, Ngebel Geothermal Project, Dairi Prima Geothermal Project and Puga Geothermal Project.

  • Revenue in AUD (TTM)2.43m
  • Net income in AUD-128.80k
  • Incorporated2006
  • Employees--
  • Location
    Oakridge International LtdSuite 3, Level 3, 89 Pirie StADELAIDE 5000AustraliaAUS
  • Phone+61 88223-0200
  • Fax+61 39642-5177
  • Websitehttps://www.oakridgeint.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.